REPORT SUMMARY
What the data shows
Executives in Medical Technology provided insider information on the price increases, gross margin, and revenue growth from 2023 and their targets for 2024. We analyzed their responses and uncovered several traits the high performing companies had in common. Discover those and other insights in our Medical Technology Pricing Benchmarks white paper.
Some Key Insights:
- European Med-Tech companies set higher targets (revenue and price increase) and were able to hit them, in contrast, North America fell short of their
- conservative targets
- Europe saw slightly higher discounting, but still achieved 4x higher net price realization
- Medium-sized companies ($500M – $1B) realized the greatest net price increase (almost 3.5x)
- Around 28% of Medical Technology companies allowed their sales team to offer discounts above 10% without management approval compared
- to 40% for other industries
